Stem Cell Trial Against COVID-19
ReeLabs Pvt. Ltd. has received permission from the Central Licensing Authority to conduct the FIRST and ONLY clinical trial in India using Mesenchymal stem cells derived from Placenta and Umbilical Cord Tissue in the fight against COVID-19.
This trial is to be conducted at Seven Hills hospital, Mumbai and BMC owned Sion Hospital. The permission is granted for ‘Randomised placebo-controlled Phase I study for the treatment of patients with COVID-19 pneumonia using intravenous administration of mixture of umbilical cord and placenta mesenchymal stem cells.'
Most Innovative Stem Cell Research Facility
ReeLabs is a proud recepient of the Global Healthcare and Pharmaceutical Award, 2021 in the category of the 'Most Innovative Stem Cell Research Facility'!
Global Health & Pharma, United Kingdom, is a universally renowned healthcare platform that especially focuses on empirical and cutting edge technologies.
ReeLabs, India is the first Asian Enterprise to have won this prestigious award, especially for its groundbreaking research against COVID-19 using its US, EU and UK patented stem cell product.
Stem Cell Banking and Therapy in India
Stem Cell Banking, and Research is our forte. With the technological know-how and expertise of banking from 10 different sources, we are India's first and only bank with the capabilities to offer Amniotic Sac, Amniotic Fluid and Placental Stem Cell Banking facility along with Cord Blood and Cord Tissue. Our commitment to stem cells has successfully helped over 1,00,000 people from all walks of life. Our tie-ups with over 300 hospitals, medical centres and specialty clinics across India helps us to be there for you whenever and wherever you need us. Using state of the art technology, we ensure the highest count and viability of cells, so that they can be effectively used for treatment, when required.
You can get in touch with us by filling out the contact form, or by giving us a call on our Toll Free no: 1800-222-454 (Mon-Fri, 10am-6pm).
ReeLabs Featured on Bio Informant
ReeLabs has been featured on Bio Informant - the World's largest Stem Cell Industry Blog, for conducting the First Stem Cell Trial Against COVID-19 in India. Read about it here
ReeLabs is a proud member of the Indian Society of Regenerative Science & Medical Tourism Association
Why choose us?
We have the technological capabilities of banking from 10 different sources, including Amniotic Sac and Placenta. We are the only company in India to do extensive research on the benefits of stem cell therapy along with banking. Click below to learn more.Why choose ReeLabs?
Stem Cell Therapy is the first line of treatment for over 80 approved disorders.
Complete list of Treatable Diseases
Have a question?
What are stem cells? How do they work? Need more information on Banking or Therapy? Whatever the question is, our team is dedicated to help you.
Call us toll free on
1800-222-454 (Mon-Fri, 10am-6pm)Or contact us here